A map has been released to display the locations of all FDA cGMP (Current Good Manufacturing Practice) warning letters issued in fiscal 2011. It is evident that the FDA is continuing its crackdown on overseas manufacturing plants as warning letters increased by 40% from last year. Mexico and India accounted for one-third of the total number of warning letters issued. It is also worthy to note that for the first time since 2009, no facility in South America received a warning letter. To read more, click here.
*image courtesy of Nick Taylor from in-pharmatechnologist.com